Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease - Wikidata - wikimedia - TriplyDB

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

http://www.wikidata.org/entity/Q24611284

about

Genetics of non-alcoholic fatty liver disease: From susceptibility and nutrient interactions to management Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise review Genetic, metabolic and environmental factors involved in the development of liver cirrhosis in Mexico Genetic background in nonalcoholic fatty liver disease: A comprehensive review Endocrine causes of nonalcoholic fatty liver disease Genetic Factors in the Pathogenesis of Nonalcoholic Fatty Liver and Steatohepatitis Studying non-alcoholic fatty liver disease with zebrafish: a confluence of optics, genetics, and physiology Pediatric fatty liver disease: role of ethnicity and genetics Missense mutation in APOC3 within the C-terminal lipid binding domain of human ApoC-III results in impaired assembly and secretion of triacylglycerol-rich very low density lipoproteins: evidence that ApoC-III plays a major role in the formation of l Non-alcoholic fatty liver disease: need for a balanced nutritional source Genetic polymorphisms of the human PNPLA3 gene are strongly associated with severity of non-alcoholic fatty liver disease in Japanese.Mechanisms for insulin resistance: common threads and missing links Non-invasive Testing for NASH and NASH with Advanced Fibrosis: Are We There Yet?The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B.Non-alcoholic fatty liver disease (NAFLD): why you should care, when you should worry, what you should do.Loss-of-function mutations in APOC3, triglycerides, and coronary disease Inflammation in nonalcoholic steatohepatitis.Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data.Gender and racial differences in nonalcoholic fatty liver disease.NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population.Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinoma Pooled genetic analysis in ultrasound measured non-alcoholic fatty liver disease in Indian subjects: A pilot study.Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.Proteomic and genomic studies of non-alcoholic fatty liver disease--clues in the pathogenesis Genetic variants of APOC3 promoter and HLA-B genes in an HIV infected cohort in northern South Africa: a pilot study.Non-alcoholic fatty liver disease in a rural, physically active, low income population in Sri Lanka.Diacylglycerol-mediated insulin resistance.Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population Lipid-induced insulin resistance: unravelling the mechanism.Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.Genetic determinants of plasma triglycerides Apolipoprotein C3 genetic polymorphisms are associated with lipids and coronary artery disease in a Chinese population.Apolipoprotein c3 gene polymorphisms are not a risk factor for developing non-alcoholic Fatty liver disease: a meta-analysis Genetic determinants of hepatic steatosis in man.Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study Lack of effect of apolipoprotein C3 polymorphisms on indices of liver steatosis, lipid profile and insulin resistance in obese Southern Europeans.

P2860

Q26741557-B657D018-C950-460B-B883-65C528DCAE42 Q26766459-3E61A7DF-441E-415A-9452-349E8720F37C Q26778035-1A387267-DCB6-4E13-AB38-953FBA722E81 Q26780248-450CDAF7-2A0D-47F8-A6CB-88AE2AB3A868 Q26780254-F547535D-653A-4315-8199-9EC69A0C112F Q26798151-434CBA43-DC94-44A4-B803-42458A3977A2 Q27010291-0889029D-C12F-45C1-B18A-ABA96A249FA3 Q27026295-F5DDF7FD-9A0E-45C1-A6E6-75C97D0B5B40 Q28240856-A5E97D0F-8A0D-4BB0-ADF4-6DD8116CDA10 Q28248994-1BF03AA9-02AB-4362-8E01-564A6CBF80E7 Q29417094-A2D3BF88-A069-46C4-8ECC-D9F86FE7C4BB Q29620447-B38F2664-A2AF-4F8A-BE3B-471A8770B4C4 Q30382278-E37F3D07-4C2E-4415-8566-58784BCA15DE Q30382395-BCF064CA-CA54-46A5-9A52-0C7F370A198F Q30389752-42265720-A476-4301-A813-2B195E4FAFC1 Q30392056-BA7EA0FA-896B-4DF6-A734-85C471F7CA27 Q30401022-D28AA2E5-94A8-4B1B-95A2-030173B6A943 Q30408720-E957B902-22F7-437D-BA44-D0CED069F444 Q30453231-A306AD86-B23F-4F5C-A288-E4345BD6E65B Q30622511-0998CD1C-A6B5-4E50-9481-5216526FD70E Q33660001-17974655-C5B7-4FE5-9F6B-C6A3DD403B05 Q33768820-662FF2AF-8F1E-4188-8CC5-EAC91ADC89E4 Q33798871-E64E40DE-4FEC-40BB-B211-4FE9EAC653EC Q33845164-197B7B2C-9E9F-4A2C-8175-A473AF33F426 Q33851563-DF436E78-FFD5-4254-B7C8-0694D1064F37 Q33886918-1363F7A0-E72A-46B0-9213-30E42FC19D24 Q34072196-6A798ABD-1803-41FA-A306-0608CE031BF2 Q34083102-4D390213-0A78-4A5E-9E7E-C086327C72E3 Q34109119-D82C20B7-C77E-41D2-B840-7E847BF75401 Q34205386-D03A1A4F-8E1A-4EAC-893A-F3FF9BDB6065 Q34326735-8E1027BB-B480-4160-B9A7-5EBBFC6B0412 Q34370958-1F42E020-E29F-46D8-AFFD-E9E1ACED4728 Q34395446-FA318D45-B54A-4574-9481-EC50EDC677F1 Q34503333-92F0E201-ED8F-4B46-8CE0-921C2A11A05D Q34515296-09B6BC20-3A90-4096-BD23-3AF8BA28FDCF Q34606616-96B2ED0C-6CEC-46C7-81C2-A15F3D8BD8E7 Q34646183-537D32D5-8D45-481D-B2F3-D883E0471E3C Q34674263-51344397-6A93-4908-8AFB-8E4D4DBA0EEF Q34799703-EEFF5EF0-B92A-437F-9D00-6308A6076201 Q35102868-8E3608D7-41A6-4743-92F6-A39A2E11CD03

P2860

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

http://www.wikidata.org/entity/Q24611284

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@ast

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@en

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@nl

type

label

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@ast

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@en

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@nl

prefLabel

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@ast

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@en

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@nl

P1433

Q24611284-D39F9361-E15A-4691-B63E-ADD9D178C221

P1476

Q24611284-CE3E5B65-08F9-4F51-9352-42C6F544C37E

P2093

Q24611284-01728BE5-77E6-4C7D-8BD9-592DDF572BB1

Q24611284-6D1CCA86-5CD4-4FE8-8E8F-23A0DB6CBEB1

Q24611284-6DF316F3-AC17-4EE8-AB6A-0761C39EDD8E

Q24611284-B0E8E06C-1B67-4090-B509-AB9C2A5BFA48

Q24611284-E8F34F21-B332-457D-9159-D54619211392

Q24611284-EF334108-CFAD-4DB5-9BD0-FE42F43816DF

Q24611284-FD74B5E2-84D0-41A2-926B-997A81871DDA

P2860

Q24611284-034B6145-300C-43CE-BD86-D885AD8EB3C5

Q24611284-0DBDDC47-C12C-4C17-A447-9FAAE2BA8CC2

Q24611284-0ED36853-477D-46E6-A59A-608ABF8DE675

Q24611284-17D301D1-19DC-4D8E-955B-77E797018DAA

Q24611284-21509880-A99B-41F8-8538-E7BCA33DDD3C

Q24611284-223EA3D8-4375-4817-9B7A-7D00B51C9403

Q24611284-3477DDC1-5F60-4C67-85CF-78BE3FE00F13

Q24611284-3C4F3620-3FB4-440B-B3FB-13DE4AE01D09

Q24611284-48DCFFE5-0B51-4381-922F-20BE79840439

Q24611284-4B735820-8B4A-443A-A183-CBFEB65EFDBD

P304

Q24611284-24A52D64-2148-4B82-A032-CD1360263350

P31

Q24611284-C84ABE74-25BE-4255-B398-E066D6C5A87C

P3181

Q24611284-81763D9D-F147-468C-A1BB-4A344C75C9BA

P356

Q24611284-47010B97-A21A-4E5E-857B-53F4F6B4E4A5

P407

Q24611284-A6CA6A5F-B87A-4DBA-A0BC-447959A5B4EF

P433

Q24611284-066BFA8F-8725-4E6E-892B-B4071053BDD6

P478

Q24611284-F9B21C32-484C-423A-B177-F8D177BFC193

P50

Q24611284-45EB0428-A147-4D04-B721-6FA5EF0CD50B

Q24611284-56674173-ABC5-4219-A6E4-977A674C3CC1

P577

Q24611284-5DC0FCE7-4514-412E-8FAC-5DD5F94E2788

P698

Q24611284-319E310C-3B8B-4513-924B-F64449076B69

P932

Q24611284-4BABD75D-DA01-4ABC-959B-86E5591F60E0

P3181

P356

P1433

The New England Journal of Medicine

P1476

Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease

@en

P2093

Ali Hariri

http://www.w3.org/2001/XMLSchema#string

Carol Nelson-Williams

http://www.w3.org/2001/XMLSchema#string

James Dziura

http://www.w3.org/2001/XMLSchema#string

Jia Nee Foo

http://www.w3.org/2001/XMLSchema#string

Richard P Lifton

http://www.w3.org/2001/XMLSchema#string

Sylvie Dufour

http://www.w3.org/2001/XMLSchema#string

Xian-Man Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance

Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in nonalcoholic fatty liver disease

Suppression of diacylglycerol acyltransferase-2 (DGAT2), but not DGAT1, with antisense oligonucleotides reverses diet-induced hepatic steatosis and insulin resistance

Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease

The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism?

Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy.

Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes.

Different patterns of postprandial lipoprotein metabolism in normal, type IIa, type III, and type IV hyperlipoproteinemic individuals. Effects of treatment with cholestyramine and gemfibrozil

Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.

Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.

P304

1082-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2704696

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJMOA0907295

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

362

http://www.w3.org/2001/XMLSchema#string

P50

Gerald I. Shulman

Kitt Falk Petersen

P577

2010-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20335584

http://www.w3.org/2001/XMLSchema#string

P932

2976042

http://www.w3.org/2001/XMLSchema#string